Published :
Tables : 52
Figures : 48
Category : Healthcare
No. of Pages : 240
Report Code : HC-1299
Drug Discovery Services Market is poised to value USD 41034 million by 2028 end at a CAGR of 14.3% during the forecast period 2022 to 2028. The process of designing a drug is called drug discovery. Molecular manipulation, random screening, drug metabolites, molecular designing, and serendipity are the most common methods of drug discovery. Drug discovery services are designed to reduce the costs and timelines involved in the discovery of new drugs. A method of drug discovery is used in pharmacology, biotechnology, and medicine to discover and design new medications. There are several steps to this process, including identification, production, depiction, selection, and assays for therapeutic utility. As soon as a compound has demonstrated its value in these assessments, it will begin the process of drug development leading to a clinical trial. The core of drug discovery services includes drug target identification, drug discovery selection, drug design based on fragments, lead compound recognition, and lead optimization. In forensics, paternity testing, disaster victim identification, and anthropology, drug discovery services are widely used, with DNA analysis being an extremely important tool in this field. Increased R&D spending, a preference among big pharmaceutical firms for outsourcing to avoid roadblocks, and a spike in demand for analytical testing and clinical trial services are the primary reasons driving this market's growth. The drug discovery services industry is expanding rapidly, owing to increased demand and supply for pharmaceuticals. Furthermore, factors like as technical developments and an increase in the adoption of novel methodologies for discovery, as well as an increase in demand for generic medications and an increase in the number of patents expiring, all contribute to the market's worldwide expansion. Increased R&D activities, the expansion of the healthcare sector, the rise in demand for generic medications, the rise in the elderly population, and technical developments in drug discovery services are all contributing to the market's growth. FutureWise Market Research has instantiated a report that provides an intricate analysis of Drug Discovery Services Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Drug Discovery Services Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Key market players involved in the Drug Discovery Services Market are: • Thermo Fisher Scientific • Merck • GE Healthcare • Albany Molecular Research, Inc (AMRI) • Charles River Laboratories International • Evotec • Pharmaceutical Product Development, LLC. (Ppd) • Jubilant Biosys • Covance • Genscript Biotech Corporation • Aurigene Discovery Technologies • Wuxi Apptec • Syngene • Eurofins Scientific • GVK Biosciences Private Limited • Laboratory Corporation of America Holdings • Lonza Group AG • Piramal Enterprises Ltd • Viva Biotech • Dalton Pharma Services • Domainex • Selvita S.A. • SRI International • BioDuro (Note: The list of the major players will be updated with the latest market scenario and trends) Drug Discovery Services Market Segmentation: By Process • Target Selection • Target Validation • Hit-to-Lead Identification • Lead Optimization • Candidate Validation By Type • Medicinal Chemistry • Biology Services • Drug Metabolism and Pharmacokinetics By Drug Type • Small Molecules • Biologics By Therapeutic Area • Oncology • Neurology • Cardiovascular Diseases • Respiratory Diseases • Diabetes • Other Therapeutics Areas By Company Type • Tier 1 Pharmaceutical Companies • Tier 2 Pharmaceutical Companies • Tier 3 Pharmaceutical Companies By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa Drug Discovery Services Market Sample Video: Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the drug discovery services market By Process, By Type, By Drug Type, By Therapeutic Area, By Company Type and By Region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
The process of designing a drug is called drug discovery. Molecular manipulation, random screening, drug metabolites, molecular designing, and serendipity are the most common methods of drug discovery. Drug discovery services are designed to reduce the costs and timelines involved in the discovery of new drugs. A method of drug discovery is used in pharmacology, biotechnology, and medicine to discover and design new medications. There are several steps to this process, including identification, production, depiction, selection, and assays for therapeutic utility. As soon as a compound has demonstrated its value in these assessments, it will begin the process of drug development leading to a clinical trial. The core of drug discovery services includes drug target identification, drug discovery selection, drug design based on fragments, lead compound recognition, and lead optimization.
In forensics, paternity testing, disaster victim identification, and anthropology, drug discovery services are widely used, with DNA analysis being an extremely important tool in this field. Increased R&D spending, a preference among big pharmaceutical firms for outsourcing to avoid roadblocks, and a spike in demand for analytical testing and clinical trial services are the primary reasons driving this market's growth.
The drug discovery services industry is expanding rapidly, owing to increased demand and supply for pharmaceuticals. Furthermore, factors like as technical developments and an increase in the adoption of novel methodologies for discovery, as well as an increase in demand for generic medications and an increase in the number of patents expiring, all contribute to the market's worldwide expansion. Increased R&D activities, the expansion of the healthcare sector, the rise in demand for generic medications, the rise in the elderly population, and technical developments in drug discovery services are all contributing to the market's growth.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Drug Discovery Services Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Drug Discovery Services Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
Key market players involved in the Drug Discovery Services Market are: • Thermo Fisher Scientific • Merck • GE Healthcare • Albany Molecular Research, Inc (AMRI) • Charles River Laboratories International • Evotec • Pharmaceutical Product Development, LLC. (Ppd) • Jubilant Biosys • Covance • Genscript Biotech Corporation • Aurigene Discovery Technologies • Wuxi Apptec • Syngene • Eurofins Scientific • GVK Biosciences Private Limited • Laboratory Corporation of America Holdings • Lonza Group AG • Piramal Enterprises Ltd • Viva Biotech • Dalton Pharma Services • Domainex • Selvita S.A. • SRI International • BioDuro (Note: The list of the major players will be updated with the latest market scenario and trends)
Drug Discovery Services Market Segmentation: By Process • Target Selection • Target Validation • Hit-to-Lead Identification • Lead Optimization • Candidate Validation By Type • Medicinal Chemistry • Biology Services • Drug Metabolism and Pharmacokinetics By Drug Type • Small Molecules • Biologics By Therapeutic Area • Oncology • Neurology • Cardiovascular Diseases • Respiratory Diseases • Diabetes • Other Therapeutics Areas By Company Type • Tier 1 Pharmaceutical Companies • Tier 2 Pharmaceutical Companies • Tier 3 Pharmaceutical Companies By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
Drug Discovery Services Market Sample Video:
Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants
FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth
Objectives of the Study: • To provide with an exhaustive analysis on the drug discovery services market By Process, By Type, By Drug Type, By Therapeutic Area, By Company Type and By Region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Drug Discovery Services Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Drug Discovery Services Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Drug Discovery Services Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Drug Discovery Services Market, By Process Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Target Selection 7.2. Target Validation 7.3. Hit-to-Lead Identification 7.4. Lead Optimization 7.5. Candidate Validation 8. Drug Discovery Services Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Medicinal Chemistry 8.2. Biology Services 8.3. Drug Metabolism and Pharmacokinetics 9. Drug Discovery Services Market, By Drug Type Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Small Molecules 9.2. Biologics 10. Drug Discovery Services Market, By Therapeutic Area Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Oncology 10.2. Neurology 10.3. Cardiovascular Diseases 10.4. Respiratory Diseases 10.5. Diabetes 10.6. Other Therapeutics Areas 11. Drug Discovery Services Market, By Company Type Historical Analysis and Forecast 2022-2028 (USD Million) 11.1. Online Stores 11.2. Retail 11.3. Others 12. North America Drug Discovery Services Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. U.S.A 12.2.2. Canada 12.2.3. Mexico 12.3. Market Size (USD Million) Forecast for North America 2022-2028 13. Latin America Drug Discovery Services Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Brazil 13.2.2. Venezuela 13.2.3. Argentina 13.2.4. Rest of Latin America 13.3. Market Size (USD Million) Forecast for Latin America 2022-2028 14. Europe Drug Discovery Services Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Germany 14.2.2. U.K 14.2.3. France 14.2.4. Italy 14.2.5. Spain 14.2.6. Russia 14.2.7. Poland 14.2.8. Rest of Europe 14.3. Market Size (USD Million) Forecast for Europe 2022-2028 15. Asia Pacific Drug Discovery Services Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Japan 15.2.2. China 15.2.3. India 15.2.4. Australia and New Zealand 15.2.5. ASEAN 15.2.6. Rest of Asia Pacific 15.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 16. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 16.2.1. GCC 16.2.2. Israel 16.2.3. South Africa 16.2.4. Rest of MEA 16.3. Market Size (USD Million) Forecast for MEA 2022-2028 17. Market Share Analysis and Competitive Landscape 17.1. Global Landscape - Key Players, Revenue and Presence 17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 17.3. Global Emerging Companies 17.4. North America - Market Share Analysis and Key Regional Players 17.5. Europe - Market Share Analysis and Key Regional Players 17.6. Asia Pacific - Market Share Analysis and Key Regional Players 17.7. Global Key Player - Growth Matrix 18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 18.1. Thermo Fisher Scientific 18.1.1. Company Overview 18.1.2. Product Portfolio 18.1.3. SWOT Analysis 18.1.4. Financial Overview 18.1.5. Strategic Overview 18.2. Merck 18.2.1. Company Overview 18.2.2. Product Portfolio 18.2.3. SWOT Analysis 18.2.4. Financial Overview 18.2.5. Strategic Overview 18.3. GE Healthcare 18.3.1. Company Overview 18.3.2. Product Portfolio 18.3.3. SWOT Analysis 18.3.4. Financial Overview 18.3.5. Strategic Overview 18.4. Albany Molecular Research, Inc. (AMRI) 18.4.1. Company Overview 18.4.2. Product Portfolio 18.4.3. SWOT Analysis 18.4.4. Financial Overview 18.4.5. Strategic Overview 18.5. Pharmaceutical Product Development, LLC. (Ppd) 18.5.1. Company Overview 18.5.2. Product Portfolio 18.5.3. SWOT Analysis 18.5.4. Financial Overview 18.5.5. Strategic Overview 18.6. Jubilant Biosys 18.6.1. Company Overview 18.6.2. Product Portfolio 18.6.3. SWOT Analysis 18.6.4. Financial Overview 18.6.5. Strategic Overview 18.7. Covance 18.7.1. Company Overview 18.7.2. Product Portfolio 18.7.3. SWOT Analysis 18.7.4. Financial Overview 18.7.5. Strategic Overview 18.8. Genscript Biotech Corporation 18.8.1. Company Overview 18.8.2. Product Portfolio 18.8.3. SWOT Analysis 18.8.4. Financial Overview 18.8.5. Strategic Overview 18.9. Aurigene Discovery Technologies 18.9.1. Company Overview 18.9.2. Product Portfolio 18.9.3. SWOT Analysis 18.9.4. Financial Overview 18.9.5. Strategic Overview 18.10.Wuxi Apptec 18.10.1. Company Overview 18.10.2. Product Portfolio 18.10.3. SWOT Analysis 18.10.4. Financial Overview 18.10.5. Strategic Overview 18.11.Syngene 18.11.1. Company Overview 18.11.2. Product Portfolio 18.11.3. SWOT Analysis 18.11.4. Financial Overview 18.11.5. Strategic Overview 18.12.Eurofins Scientific 18.12.1. Company Overview 18.12.2. Product Portfolio 18.12.3. SWOT Analysis 18.12.4. Financial Overview 18.12.5. Strategic Overview 18.13.GVK Biosciences Private Limited 18.13.1. Company Overview 18.13.2. Product Portfolio 18.13.3. SWOT Analysis 18.13.4. Financial Overview 18.13.5. Strategic Overview 18.14.Laboratory Corporation of America Holdings 18.14.1. Company Overview 18.14.2. Product Portfolio 18.14.3. SWOT Analysis 18.14.4. Financial Overview 18.14.5. Strategic Overview 18.15.Lonza Group AG 18.15.1. Company Overview 18.15.2. Product Portfolio 18.15.3. SWOT Analysis 18.15.4. Financial Overview 18.15.5. Strategic Overview 18.16.Piramal Enterprises Ltd. 18.16.1. Company Overview 18.16.2. Product Portfolio 18.16.3. SWOT Analysis 18.16.4. Financial Overview 18.16.5. Strategic Overview 18.17.Viva Biotech 18.17.1. Company Overview 18.17.2. Product Portfolio 18.17.3. SWOT Analysis 18.17.4. Financial Overview 18.17.5. Strategic Overview 18.18.Dalton Pharma Services 18.18.1. Company Overview 18.18.2. Product Portfolio 18.18.3. SWOT Analysis 18.18.4. Financial Overview 18.18.5. Strategic Overview 18.19.Domainex 18.19.1. Company Overview 18.19.2. Product Portfolio 18.19.3. SWOT Analysis 18.19.4. Financial Overview 18.19.5. Strategic Overview 18.20.Selvita S.A. 18.20.1. Company Overview 18.20.2. Product Portfolio 18.20.3. SWOT Analysis 18.20.4. Financial Overview 18.20.5. Strategic Overview 18.21.SRI International 18.21.1. Company Overview 18.21.2. Product Portfolio 18.21.3. SWOT Analysis 18.21.4. Financial Overview 18.21.5. Strategic Overview 18.22.BioDuro 18.22.1. Company Overview 18.22.2. Product Portfolio 18.22.3. SWOT Analysis 18.22.4. Financial Overview 18.22.5. Strategic Overview 19. Pre and Post COVID-19 Impact 19.1. Positive influence on the healthcare industry 19.2. The financial disruption of the manufacturing sector 19.3. Impact of COVID-19 on emerging companies 19.4. Significant mandates in the healthcare regulations initiated by administrations 19.5. The overall economic slowdown of the developing and developed nations 20. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Drug Discovery Services Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Drug Discovery Services Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Drug Discovery Services Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Drug Discovery Services Market, By Process Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Target Selection 7.2. Target Validation 7.3. Hit-to-Lead Identification 7.4. Lead Optimization 7.5. Candidate Validation
8. Drug Discovery Services Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Medicinal Chemistry 8.2. Biology Services 8.3. Drug Metabolism and Pharmacokinetics
9. Drug Discovery Services Market, By Drug Type Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Small Molecules 9.2. Biologics
10. Drug Discovery Services Market, By Therapeutic Area Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Oncology 10.2. Neurology 10.3. Cardiovascular Diseases 10.4. Respiratory Diseases 10.5. Diabetes 10.6. Other Therapeutics Areas
11. Drug Discovery Services Market, By Company Type Historical Analysis and Forecast 2022-2028 (USD Million) 11.1. Online Stores 11.2. Retail 11.3. Others
12. North America Drug Discovery Services Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. U.S.A 12.2.2. Canada 12.2.3. Mexico 12.3. Market Size (USD Million) Forecast for North America 2022-2028
13. Latin America Drug Discovery Services Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Brazil 13.2.2. Venezuela 13.2.3. Argentina 13.2.4. Rest of Latin America 13.3. Market Size (USD Million) Forecast for Latin America 2022-2028
14. Europe Drug Discovery Services Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Germany 14.2.2. U.K 14.2.3. France 14.2.4. Italy 14.2.5. Spain 14.2.6. Russia 14.2.7. Poland 14.2.8. Rest of Europe 14.3. Market Size (USD Million) Forecast for Europe 2022-2028
15. Asia Pacific Drug Discovery Services Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Japan 15.2.2. China 15.2.3. India 15.2.4. Australia and New Zealand 15.2.5. ASEAN 15.2.6. Rest of Asia Pacific 15.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
16. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 16.2.1. GCC 16.2.2. Israel 16.2.3. South Africa 16.2.4. Rest of MEA 16.3. Market Size (USD Million) Forecast for MEA 2022-2028
17. Market Share Analysis and Competitive Landscape 17.1. Global Landscape - Key Players, Revenue and Presence 17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 17.3. Global Emerging Companies 17.4. North America - Market Share Analysis and Key Regional Players 17.5. Europe - Market Share Analysis and Key Regional Players 17.6. Asia Pacific - Market Share Analysis and Key Regional Players 17.7. Global Key Player - Growth Matrix
18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 18.1. Thermo Fisher Scientific 18.1.1. Company Overview 18.1.2. Product Portfolio 18.1.3. SWOT Analysis 18.1.4. Financial Overview 18.1.5. Strategic Overview 18.2. Merck 18.2.1. Company Overview 18.2.2. Product Portfolio 18.2.3. SWOT Analysis 18.2.4. Financial Overview 18.2.5. Strategic Overview 18.3. GE Healthcare 18.3.1. Company Overview 18.3.2. Product Portfolio 18.3.3. SWOT Analysis 18.3.4. Financial Overview 18.3.5. Strategic Overview 18.4. Albany Molecular Research, Inc. (AMRI) 18.4.1. Company Overview 18.4.2. Product Portfolio 18.4.3. SWOT Analysis 18.4.4. Financial Overview 18.4.5. Strategic Overview 18.5. Pharmaceutical Product Development, LLC. (Ppd) 18.5.1. Company Overview 18.5.2. Product Portfolio 18.5.3. SWOT Analysis 18.5.4. Financial Overview 18.5.5. Strategic Overview 18.6. Jubilant Biosys 18.6.1. Company Overview 18.6.2. Product Portfolio 18.6.3. SWOT Analysis 18.6.4. Financial Overview 18.6.5. Strategic Overview 18.7. Covance 18.7.1. Company Overview 18.7.2. Product Portfolio 18.7.3. SWOT Analysis 18.7.4. Financial Overview 18.7.5. Strategic Overview 18.8. Genscript Biotech Corporation 18.8.1. Company Overview 18.8.2. Product Portfolio 18.8.3. SWOT Analysis 18.8.4. Financial Overview 18.8.5. Strategic Overview 18.9. Aurigene Discovery Technologies 18.9.1. Company Overview 18.9.2. Product Portfolio 18.9.3. SWOT Analysis 18.9.4. Financial Overview 18.9.5. Strategic Overview 18.10.Wuxi Apptec 18.10.1. Company Overview 18.10.2. Product Portfolio 18.10.3. SWOT Analysis 18.10.4. Financial Overview 18.10.5. Strategic Overview 18.11.Syngene 18.11.1. Company Overview 18.11.2. Product Portfolio 18.11.3. SWOT Analysis 18.11.4. Financial Overview 18.11.5. Strategic Overview 18.12.Eurofins Scientific 18.12.1. Company Overview 18.12.2. Product Portfolio 18.12.3. SWOT Analysis 18.12.4. Financial Overview 18.12.5. Strategic Overview 18.13.GVK Biosciences Private Limited 18.13.1. Company Overview 18.13.2. Product Portfolio 18.13.3. SWOT Analysis 18.13.4. Financial Overview 18.13.5. Strategic Overview 18.14.Laboratory Corporation of America Holdings 18.14.1. Company Overview 18.14.2. Product Portfolio 18.14.3. SWOT Analysis 18.14.4. Financial Overview 18.14.5. Strategic Overview 18.15.Lonza Group AG 18.15.1. Company Overview 18.15.2. Product Portfolio 18.15.3. SWOT Analysis 18.15.4. Financial Overview 18.15.5. Strategic Overview 18.16.Piramal Enterprises Ltd. 18.16.1. Company Overview 18.16.2. Product Portfolio 18.16.3. SWOT Analysis 18.16.4. Financial Overview 18.16.5. Strategic Overview 18.17.Viva Biotech 18.17.1. Company Overview 18.17.2. Product Portfolio 18.17.3. SWOT Analysis 18.17.4. Financial Overview 18.17.5. Strategic Overview 18.18.Dalton Pharma Services 18.18.1. Company Overview 18.18.2. Product Portfolio 18.18.3. SWOT Analysis 18.18.4. Financial Overview 18.18.5. Strategic Overview 18.19.Domainex 18.19.1. Company Overview 18.19.2. Product Portfolio 18.19.3. SWOT Analysis 18.19.4. Financial Overview 18.19.5. Strategic Overview 18.20.Selvita S.A. 18.20.1. Company Overview 18.20.2. Product Portfolio 18.20.3. SWOT Analysis 18.20.4. Financial Overview 18.20.5. Strategic Overview 18.21.SRI International 18.21.1. Company Overview 18.21.2. Product Portfolio 18.21.3. SWOT Analysis 18.21.4. Financial Overview 18.21.5. Strategic Overview 18.22.BioDuro 18.22.1. Company Overview 18.22.2. Product Portfolio 18.22.3. SWOT Analysis 18.22.4. Financial Overview 18.22.5. Strategic Overview
19. Pre and Post COVID-19 Impact 19.1. Positive influence on the healthcare industry 19.2. The financial disruption of the manufacturing sector 19.3. Impact of COVID-19 on emerging companies 19.4. Significant mandates in the healthcare regulations initiated by administrations 19.5. The overall economic slowdown of the developing and developed nations
20. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics